Patents by Inventor Judd M. Berman

Judd M. Berman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agents, and methods of making and using the same
    Patent number: 8450307
    Abstract: In part, the present invention is directed to antibacterial compounds.
    Type: Grant
    Filed: June 6, 2005
    Date of Patent: May 28, 2013
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Bruce J. Sargent, Henry Pauls, Judd M. Berman, Jailall Ramnauth, Peter Sampson, Andras Toro, Fernando J. Martin, Matthew D. Surman, Helene Y. Decornez, David D. Manning
  • Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
    Publication number: 20120010127
    Abstract: In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    Type: Application
    Filed: December 8, 2010
    Publication date: January 12, 2012
    Inventors: JUDD M. BERMAN, MOLLY B. SCHMID, JOHN D. MENDLEIN, NACHUM KAPLAN
  • Compositions comprising multiple bioactive agents, and methods of using the same
    Patent number: 7879872
    Abstract: In part, the present invention is directed to compositions having a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions having a compound of formulas I-III and at least one other antibacterial agent.
    Type: Grant
    Filed: September 19, 2005
    Date of Patent: February 1, 2011
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Judd M. Berman, Molly B. Schmid, John D. Mendlein, Nachum Kaplan
  • Heterocyclic compounds, methods of making them and their use in therapy
    Patent number: 7790709
    Abstract: In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 7, 2010
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Judd M. Berman, Peter Sampson, Heinz W. Pauls, Jailall Ramnauth, David Douglas Manning, Matthew D. Surman, Dejian Xie, Helene Y. Decornez
  • Therapeutic agents, and methods of making and using the same
    Publication number: 20100093705
    Abstract: In part, the present invention is directed to antibacterial compounds.
    Type: Application
    Filed: June 6, 2005
    Publication date: April 15, 2010
    Inventors: Bruce J. Sargent, Henry Pauls, Judd M. Berman, Jailall Ramnauth, Peter Sampson, Andras Toro, Fernando J. Martin, Matthew D. Surman, Helene Y. Decornez, David D. Manning
  • Purified FabI polypeptides from
    Patent number: 7601526
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein derived from Fransicella tularensis comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: October 13, 2009
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Judd M. Berman, Molly B. Schmid, Donald E. Awrey, Teresa Clarke, Bryan Beattie, Mandy Dorsey
  • 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
    Publication number: 20090156578
    Abstract: In part, the present invention is directed towards compounds with FabI inhibiting properties. Such compounds may also inhibit other enzymes, including those similar to FabI either structurally or functionally, for example, Fab K. Kits and compositions that include the disclosed compounds are also provided. Methods of treating a subject with a bacterial illness is also disclosed.
    Type: Application
    Filed: December 1, 2006
    Publication date: June 18, 2009
    Inventors: Henry Pauls, Judd M. Berman
  • Novel purified FabI polypeptides from fransicella tularensis
    Publication number: 20080108793
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: December 28, 2006
    Publication date: May 8, 2008
    Inventors: Judd M. Berman, Molly B. Schmid, Donald E. Awrey, Teresa Clarke McGrath, Bryan Beattie, Mandy Dorsey